|
1
|
Dickersin GR, Kline IW and Scully RE:
Small cell carcinoma of the ovary with hypercalcemia: a report of
eleven cases. Cancer. 49:188–197. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Young RH, Oliva E and Scully RE: Small
cell carcinoma of the hypercalcemic type in the ovary. Gynecol
Oncol. 57:7–8. 1995.PubMed/NCBI
|
|
3
|
Scully RE: Atlas of tumor pathology:
tumors of the ovary and maldeveloped gonads. Armed Forces Institute
of Pathology; Washington DC: 1979
|
|
4
|
Eichhorn JH and Young RH: Transitional
cell carcinoma of the ovary: a morphologic study of 100 cases with
emphasis on differential diagnosis. Am J Surg Pathol. 28:453–463.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Geisinger KR, Kute TE, Pettenati MJ, et
al: Characterization of a human ovarian carcinoma cell line with
estrogen and progesterone receptors. Cancer. 63:280–288. 1989.
View Article : Google Scholar
|
|
6
|
Hamilton TC, Young RC, McKoy WM, et al:
Characterization of a human ovarian carcinoma cell line
(NIH:OVCAR-3) with androgen and estrogen receptors. Cancer Res.
43:5379–5389. 1983.PubMed/NCBI
|
|
7
|
Poels LG, Jap PH, Ramaekers FF, et al:
Characterization of a hormone-producing ovarian carcinoma cell
line. Gynecol Oncol. 32:203–214. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bible KC, Boerner SA, Kirkland K, et al:
Characterization of an ovarian carcinoma cell line resistant to
cisplatin and flavopiridol. Clin Cancer Res. 6:661–670.
2000.PubMed/NCBI
|
|
9
|
Ohi S, Niimi S, Okada N, et al:
Establishment and characterization of a human ovarian small cell
carcinoma, hypercalcemic type, cell line (OS-1) secreting PTH,
PthrP and ACTH--special reference to the susceptibility of
anti-cancer drugs. Hum Cell. 17:203–209. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ulbright TM, Roth LM, Stehman FB, Talerman
A and Senekjian EK: Poorly differentiated (small cell) carcinoma of
the ovary in young women: evidence supporting a germ cell origin.
Hum Pathol. 18:175–184. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Aguirre P, Thor AD and Scully RE: Ovarian
small cell carcinoma. Histogenetic considerations based on
immunohistochemical and other findings. Am J Clin Pathol.
92:140–149. 1989.PubMed/NCBI
|
|
12
|
Walt H, Hornung R, Fink D, et al:
Hypercalcemic-type of small cell carcinoma of the ovary:
characterization of a new tumor line. Anticancer Res. 21:3253–3259.
2001.PubMed/NCBI
|
|
13
|
McCluggage WG, Oliva E, Connolly LE,
McBride HA and Young RH: An immunohistochemical analysis of ovarian
small cell carcinoma of hypercalcemic type. Int J Gynecol Pathol.
23:330–336. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Scully RE: Small cell carcinoma of
hypercalcemic type. Int J Gynecol Pathol. 12:148–152. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Eichhorn JH, Bell DA, Young RH, et al: DNA
content and proliferative activity in ovarian small cell carcinomas
of the hypercalcemic type. Implications for diagnosis, prognosis,
and histogenesis. Am J Clin Pathol. 98:579–586. 1992.PubMed/NCBI
|
|
16
|
Shrimali RK, Correa PD and Reed NS:
Dose-dense and dose-intense chemotherapy for small cell ovarian
cancer: 2 cases and review of literature. Med Oncol. 28:766–770.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Harrison ML, Hoskins P, du Bois A, et al:
Small cell of the ovary, hypercalcemic type - analysis of combined
experience and recommendation for management. A GCIG study. Gynecol
Oncol. 100:233–238. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Benrubi GI, Pitel P and Lammert N: Small
cell carcinoma of the ovary with hypercalcemia responsive to
sequencing chemotherapy. South Med J. 86:247–248. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Reed WC: Small cell carcinoma of the ovary
with hypercalcemia: report of a case of survival without recurrence
5 years after surgery and chemotherapy. Gynecol Oncol. 56:452–455.
1995.PubMed/NCBI
|
|
20
|
Barondeau J, Rodgers M, Braun L, Azarow K,
Forouhar M and Faucette K: Small cell ovarian carcinoma: a rare,
aggressive tumor masquerading as constipation in a teenager with a
fatal outcome. J Pediatr Hematol Oncol. 32:e139–e141. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Dykgraaf RH, de Jong D, van Veen M,
Ewing-Graham PC, Helmerhorst TJ and van der Burg ME: Clinical
management of ovarian small-cell carcinoma of the hypercalcemic
type: a proposal for conservative surgery in an advanced stage of
disease. Int J Gynecol Cancer. 19:348–353. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Distelmaier F, Calaminus G, Harms D, et
al: Ovarian small cell carcinoma of the hypercalcemic type in
children and adolescents: a prognostically unfavorable but curable
disease. Cancer. 107:2298–2306. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Gebert A and Preiss G: A simple method for
the acquisition of high-quality digital images from analog scanning
electron microscopes. J Microsc. 191:297–302. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Bertram C and Hass R: Cellular senescence
of human mammary epithelial cells (HMEC) is associated with an
altered MMP-7/HB-EGF signaling and increased formation of
elastin-like structures. Mech Ageing Dev. 130:657–669. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Schlegelberger B, Metzke S, Harder S,
Zühlke-Jenisch R, Zhang Y and Siebert R: Classical and Molecular
Cytogenetics of Tumor Cells. Springer Verlag; Heidelberg: 1999
|
|
26
|
Shaffer L, Slovak M and Champbell L: ISCN
- An International System for Human Cytogenetic Nomenclature. S.
Karger AG; Basel: 2009
|
|
27
|
Gohring G, Hanke C, Kratz C, et al:
Fluorescence in situ hybridization using the subtelomeric 11q probe
as a diagnostic tool for congenital thrombocytopenia. Ann Hematol.
85:883–885. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Schambach A, Galla M, Modlich U, Will E,
Chandra S, Reeves L, Colbert M, Williams DA, von Kalle C and Baum
C: Lentiviral vectors pseudotyped with murine ecotropic envelope:
increased biosafety and convenience in preclinical research. Exp
Hematol. 34:588–592. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
McCluggage WG, McKenna M and McBride HA:
CD56 is a sensitive and diagnostically useful immunohistochemical
marker of ovarian sex cord-stromal tumors. Int J Gynecol Pathol.
26:322–327. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ohishi Y, Kaku T, Oya M, Kobayashi H, Wake
N and Tsuneyoshi M: CD56 expression in ovarian granulosa cell
tumors, and its diagnostic utility and pitfalls. Gynecol Oncol.
107:30–38. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Majore I, Moretti P, Hass R and Kasper C:
Identification of subpopulations in mesenchymal stem cell-like
cultures from human umbilical cord. Cell Commun Signal. 7:62009.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lavrentieva A, Majore I, Kasper C and Hass
R: Effects of hypoxic culture conditions on umbilical cord-derived
human mesenchymal stem cells. Cell Commun Signal. 8:182010.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Pirozzi G, Tirion V, Camerlingo R, et al:
Epithelial to mesenchymal transition by TGFbeta-1 induction
increases stemness characteristics in primary non small cell lung
cancer cell line. PLoS One. 6:e215482011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Martinez-Borges AR, Petty JK, Hurt G,
Stribling JT, Press JZ and Castellino SM: Familial small cell
carcinoma of the ovary. Pediatr Blood Cancer. 53:1334–1336. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Denison SR, Callahan G, Becker NA,
Phillips LA and Smith DI: Characterization of FRA6E and its
potential role in autosomal recessive juvenile parkinsonism and
ovarian cancer. Genes Chromosomes Cancer. 38:40–52. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Kamal M, Shaaban AM, Zhang L, et al: Loss
of CSMD1 expression is associated with high tumour grade and poor
survival in invasive ductal breast carcinoma. Breast Cancer Res
Treat. 121:555–563. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Park SY, Kwon HJ, Lee HE, et al: Promoter
CpG island hyper-methylation during breast cancer progression.
Virchows Arch. 458:73–84. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Turnbull C, Rapley EA, Seal S, et al:
Variants near DMRT1, TERT and ATF7IP are associated with testicular
germ cell cancer. Nat Genet. 42:604–607. 2010. View Article : Google Scholar : PubMed/NCBI
|
